Skip to content

Targeting the Conus Medullaris With ECAP-Controlled Closed-Loop SCS for Treatment of Chronic Pelvic Pain: HOPE Trial

RecruitingNCT06413277
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The aim of the study is to evaluate the effectiveness of using ECAP (electrically evoked compound action potential)-controlled CL (closed-loop) SCS (spinal cord stimulation) to treat chronic pelvic pain by stimulating an area in the spine called the conus medullaris (the lowermost tapering extremity of the spinal cord).

Study details

Official title
Targeting the Conus Medullaris With ECAP-Controlled Closed-Loop SCS for the Treatment of Chronic Pelvic Pain: HOPE Trial
Conditions
Interventions
  • Device: Saluda Evoke Smart SCS System
Sponsor
Ainsworth Institute of Pain Management
Collaborators
Saluda Medical Pty Ltd
Start date
2024-02-05
Primary completion
2026-01-01
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Subject is 18 years of age or older at the time of enrollment. 2. Subject has a minimum Visual Analog Scale (VAS) score of 60 mm or higher (where 100 mm pain) at baseline. 3. Subject has been diagnosed with chronic intractable pain of the trunk and/or limbs specifically related to pelvic/genital/perineal/anorectal pain, which has been refractory to conservative therapy for a minimum of 6 months. 4. Subject has pain resulting from a known injury (surgery or trauma). 5. Subject has been clinically diagnosed with chronic pelvic pain (pain that occurs in the region of the pelvis), including diagnoses such as, but not limited to, complex regional pain syndrome (CRPS types 1 and 2), postsurgical pain, post-traumatic injury pain, interstitial cystitis/painful bladder syndrome, post-hysterectomy pain, post-prostatectomy pain, vulvodynia, chronic ovarian pain, and pudendal neuralgia of a known cause. 6. Subject is an appropriate candidate for the surgical procedures required in this study based on the clinical judgment of the implanting physician. 7. Subject is willing and capable of giving informed consent. 8. Subject is willing and able to comply with study-related requirements, procedures, and visits. Exclusion Criteria: 1. Subject is pregnant or nursing. 2. Subject is involved in a malignancy or injury claim under current litigation or has pending/approved worker's compensation claim. 3. Subject's mechanism of pain is unknown. 4. Suspected cause and onset of pain are more than 30 days apart. 5. Subject has history of small fiber neuropathy, mitochondrial disease, fibromyalgia, addiction, CRPS in secondary pain area, and/or atypical facial pain. 6. Subject has been diagnosed with Crohn's Disease, Irritable Bowel Syndrome, ulcerous colitis, or any other inflammatory disease that is ongoing. 7. Subject has a medical condition or pain in other area(s), not intended to be treated with SCS, that could interfere with study procedures, as determined by the Investigator. 8. Subject has a history of sexual abuse and/or sexual trauma. 9. Subject has a history of unmanaged depression or anxiety that pre-dates the onset of symptoms. 10. Subject is using greater than 100 MME (morphine milligram equivalents) of opioids at baseline. 11. Subject shows evidence of an active, disruptive psychological or psychiatric disorder or other known condition significant enough to impact perception of pain, compliance of intervention, and/or ability to evaluate treatm…

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06413277